anti αv antibody Search Results


93
Bio-Techne corporation human integrin alpha v beta 3 pe-conjugated antibody
Human Integrin Alpha V Beta 3 Pe Conjugated Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+%CE%B1v+antibody/Human+Integrin+alpha+V+beta+3+PE-conjugated+Antibody/bio-techne+corporation___fab3050p
Average 93 stars, based on 1 article reviews
human integrin alpha v beta 3 pe-conjugated antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Cymbus Biotechnology pe-labeled anti-human αv-integrin antibody
Pe Labeled Anti Human αv Integrin Antibody, supplied by Cymbus Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+%CE%B1v+antibody/pe+labeled+anti+human+%CE%B1v+integrin+antibody/us07238777-328-11-14
Average 90 stars, based on 1 article reviews
pe-labeled anti-human αv-integrin antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Serono abituzumab (emd 525797, anti-αv integrin antibody
Selected clinical trials of agents targeting integrins. Non-exhaustive listing of the recent most important clinical studies with <t> integrin </t> inhibitors and their salient features and results).
Abituzumab (Emd 525797, Anti αv Integrin Antibody, supplied by Serono, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+%CE%B1v+antibody/abituzumab++emd+525797++anti+%CE%B1v+integrin+antibody/pmc06678560-24-4-6
Average 90 stars, based on 1 article reviews
abituzumab (emd 525797, anti-αv integrin antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Enzo Biochem anti-αv (cd51) antibody
Selected clinical trials of agents targeting integrins. Non-exhaustive listing of the recent most important clinical studies with <t> integrin </t> inhibitors and their salient features and results).
Anti αv (Cd51) Antibody, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+%CE%B1v+antibody/anti+%CE%B1v++cd51++antibody/pm37704610-311-1-5
Average 90 stars, based on 1 article reviews
anti-αv (cd51) antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck & Co anti-αv
Selected clinical trials of agents targeting integrins. Non-exhaustive listing of the recent most important clinical studies with <t> integrin </t> inhibitors and their salient features and results).
Anti αv, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+%CE%B1v+antibody/17e6/pmc02802395-105-12-14
Average 90 stars, based on 1 article reviews
anti-αv - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Becton Dickinson anti-rat αv antibody
Selected clinical trials of agents targeting integrins. Non-exhaustive listing of the recent most important clinical studies with <t> integrin </t> inhibitors and their salient features and results).
Anti Rat αv Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+%CE%B1v+antibody/anti+rat+%CE%B1v+antibody/us08445006-166-41-53
Average 90 stars, based on 1 article reviews
anti-rat αv antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Enzo Biochem anti-αv integrin antibody l230
Selected clinical trials of agents targeting integrins. Non-exhaustive listing of the recent most important clinical studies with <t> integrin </t> inhibitors and their salient features and results).
Anti αv Integrin Antibody L230, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+%CE%B1v+antibody/anti+%CE%B1v+integrin+antibody+l230/pmc02862273-151-57-61
Average 90 stars, based on 1 article reviews
anti-αv integrin antibody l230 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Affinity Biosciences anti-integrin αv antibody
Design and characterization of PCB/INS particles. (A) The strategy for construction of PCB/INS particles/capsule. (B) The loading efficiency and (C) loading content of insulin for different PCB/INS particles at mass ratio of 8:1 and 10:1 between PCB and insulin, respectively. (D) TEM images of particles. The particles were negatively stained with phosphotungstic acid. The scale bar was 500 nm, 2 µm and 200 nm for PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles image, respectively. (E) The 3D-SIM images of the PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles with FITC-labeled insulin. The white scale bar: 5 µm. The yellow scale bar in insert images: <t>1</t> µm. The mean ± SD was shown (n = 3). n.s. > 0.05, * P < 0.05.
Anti Integrin αv Antibody, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+%CE%B1v+antibody/anti+integrin+%CE%B1v+antibody/pmc07977443-183-3-8
Average 90 stars, based on 1 article reviews
anti-integrin αv antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Immunotec inc anti-αv integrin antibody clone 69-6-5
Design and characterization of PCB/INS particles. (A) The strategy for construction of PCB/INS particles/capsule. (B) The loading efficiency and (C) loading content of insulin for different PCB/INS particles at mass ratio of 8:1 and 10:1 between PCB and insulin, respectively. (D) TEM images of particles. The particles were negatively stained with phosphotungstic acid. The scale bar was 500 nm, 2 µm and 200 nm for PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles image, respectively. (E) The 3D-SIM images of the PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles with FITC-labeled insulin. The white scale bar: 5 µm. The yellow scale bar in insert images: <t>1</t> µm. The mean ± SD was shown (n = 3). n.s. > 0.05, * P < 0.05.
Anti αv Integrin Antibody Clone 69 6 5, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+%CE%B1v+antibody/anti+%CE%B1v+integrin+antibody+clone+69+6+5/us07037666-198-6-14
Average 90 stars, based on 1 article reviews
anti-αv integrin antibody clone 69-6-5 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Biodesign International Inc anti-alphav integrin monoclonal antibody 69-6-5
Design and characterization of PCB/INS particles. (A) The strategy for construction of PCB/INS particles/capsule. (B) The loading efficiency and (C) loading content of insulin for different PCB/INS particles at mass ratio of 8:1 and 10:1 between PCB and insulin, respectively. (D) TEM images of particles. The particles were negatively stained with phosphotungstic acid. The scale bar was 500 nm, 2 µm and 200 nm for PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles image, respectively. (E) The 3D-SIM images of the PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles with FITC-labeled insulin. The white scale bar: 5 µm. The yellow scale bar in insert images: <t>1</t> µm. The mean ± SD was shown (n = 3). n.s. > 0.05, * P < 0.05.
Anti Alphav Integrin Monoclonal Antibody 69 6 5, supplied by Biodesign International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+%CE%B1v+antibody/anti+alphav+integrin+monoclonal+antibody+69+6+5/pmc01474805-136-60-54
Average 90 stars, based on 1 article reviews
anti-alphav integrin monoclonal antibody 69-6-5 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Affinity Biosciences rabbit anti-integrin αv antibody
Design and characterization of PCB/INS particles. (A) The strategy for construction of PCB/INS particles/capsule. (B) The loading efficiency and (C) loading content of insulin for different PCB/INS particles at mass ratio of 8:1 and 10:1 between PCB and insulin, respectively. (D) TEM images of particles. The particles were negatively stained with phosphotungstic acid. The scale bar was 500 nm, 2 µm and 200 nm for PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles image, respectively. (E) The 3D-SIM images of the PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles with FITC-labeled insulin. The white scale bar: 5 µm. The yellow scale bar in insert images: <t>1</t> µm. The mean ± SD was shown (n = 3). n.s. > 0.05, * P < 0.05.
Rabbit Anti Integrin αv Antibody, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+%CE%B1v+antibody/rabbit+anti+integrin+%CE%B1v+antibody/pm35907353-96-3-8
Average 90 stars, based on 1 article reviews
rabbit anti-integrin αv antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Affinity Biosciences rabbit anti-human antibodies for integrin αv df6815
Design and characterization of PCB/INS particles. (A) The strategy for construction of PCB/INS particles/capsule. (B) The loading efficiency and (C) loading content of insulin for different PCB/INS particles at mass ratio of 8:1 and 10:1 between PCB and insulin, respectively. (D) TEM images of particles. The particles were negatively stained with phosphotungstic acid. The scale bar was 500 nm, 2 µm and 200 nm for PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles image, respectively. (E) The 3D-SIM images of the PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles with FITC-labeled insulin. The white scale bar: 5 µm. The yellow scale bar in insert images: <t>1</t> µm. The mean ± SD was shown (n = 3). n.s. > 0.05, * P < 0.05.
Rabbit Anti Human Antibodies For Integrin αv Df6815, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+%CE%B1v+antibody/rabbit+anti+human+antibodies+for+integrin+%CE%B1v+df6815/pm34426644-48-4-16
Average 90 stars, based on 1 article reviews
rabbit anti-human antibodies for integrin αv df6815 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Selected clinical trials of agents targeting integrins. Non-exhaustive listing of the recent most important clinical studies with  integrin  inhibitors and their salient features and results).

Journal: Cancers

Article Title: Are Integrins Still Practicable Targets for Anti-Cancer Therapy?

doi: 10.3390/cancers11070978

Figure Lengend Snippet: Selected clinical trials of agents targeting integrins. Non-exhaustive listing of the recent most important clinical studies with integrin inhibitors and their salient features and results).

Article Snippet: Abituzumab (EMD 525797, anti-αV integrin antibody) (Merck-Serono): total no. of trials 3 , , , , , , .

Techniques: Activity Assay

Design and characterization of PCB/INS particles. (A) The strategy for construction of PCB/INS particles/capsule. (B) The loading efficiency and (C) loading content of insulin for different PCB/INS particles at mass ratio of 8:1 and 10:1 between PCB and insulin, respectively. (D) TEM images of particles. The particles were negatively stained with phosphotungstic acid. The scale bar was 500 nm, 2 µm and 200 nm for PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles image, respectively. (E) The 3D-SIM images of the PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles with FITC-labeled insulin. The white scale bar: 5 µm. The yellow scale bar in insert images: 1 µm. The mean ± SD was shown (n = 3). n.s. > 0.05, * P < 0.05.

Journal: Theranostics

Article Title: Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery

doi: 10.7150/thno.54176

Figure Lengend Snippet: Design and characterization of PCB/INS particles. (A) The strategy for construction of PCB/INS particles/capsule. (B) The loading efficiency and (C) loading content of insulin for different PCB/INS particles at mass ratio of 8:1 and 10:1 between PCB and insulin, respectively. (D) TEM images of particles. The particles were negatively stained with phosphotungstic acid. The scale bar was 500 nm, 2 µm and 200 nm for PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles image, respectively. (E) The 3D-SIM images of the PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles with FITC-labeled insulin. The white scale bar: 5 µm. The yellow scale bar in insert images: 1 µm. The mean ± SD was shown (n = 3). n.s. > 0.05, * P < 0.05.

Article Snippet: Anti-integrin αV and β1 antibodies were purchased from Affinity Biosciences LTD. All plates used in cellular experiments were Corning Incorporated.

Techniques: Staining, Labeling

The release and activity of insulin. (A) The zeta potential of particles at different pH microenvironments. (B) Release profiles of insulin from particles at distinct pH microenvironment. (C) TEM images of PCB/INS particles in phosphate buffer saline (PBS) (pH 7.4) after 24 h incubation. The particles were negatively stained with phosphotungstic acid. The white arrows indicated the fragments. The scale bar was 500 nm, 1 µm and 200 nm for PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles image, respectively. (D) CD spectra of the native insulin and insulin released from the particles. (E) The percentage of insulin undergraded at different time points in the trypsin solution. (F) Representative motion trajectories of the PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles with FITC-labeled insulin in mucus at a time lapse of 7 s. The mean ± SD was shown (n = 3).

Journal: Theranostics

Article Title: Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery

doi: 10.7150/thno.54176

Figure Lengend Snippet: The release and activity of insulin. (A) The zeta potential of particles at different pH microenvironments. (B) Release profiles of insulin from particles at distinct pH microenvironment. (C) TEM images of PCB/INS particles in phosphate buffer saline (PBS) (pH 7.4) after 24 h incubation. The particles were negatively stained with phosphotungstic acid. The white arrows indicated the fragments. The scale bar was 500 nm, 1 µm and 200 nm for PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles image, respectively. (D) CD spectra of the native insulin and insulin released from the particles. (E) The percentage of insulin undergraded at different time points in the trypsin solution. (F) Representative motion trajectories of the PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles with FITC-labeled insulin in mucus at a time lapse of 7 s. The mean ± SD was shown (n = 3).

Article Snippet: Anti-integrin αV and β1 antibodies were purchased from Affinity Biosciences LTD. All plates used in cellular experiments were Corning Incorporated.

Techniques: Activity Assay, Zeta Potential Analyzer, Saline, Incubation, Staining, Circular Dichroism, Labeling

The CLDN4 protein and mRNA level of Caco-2 cell monolayers after treatment. (A) Western blot results of CLDN4 after 2 h of PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles incubation at a concentration of 5 µg PCB/mL or removing. (B) Western bands were scanned and normalized to the gray values of internal control β-actin. Quantified results of CLDN4 in (A) using ImageJ. The data was relative to the untreated control in each Western band. The untreated control was settled to 1. (C) Fluorescence images collected by CLSM after 2 h of PCB 122 /INS particles treatment or removal. CLDN4 was shown in green, and cell nuclei stained with DAPI were in blue. (D) Relative CLDN4 mRNA level in Caco-2 cells after 2 h of PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles incubation or removal. The mean ± SD was shown (n = 3). * P < 0.05, ** P < 0.01.

Journal: Theranostics

Article Title: Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery

doi: 10.7150/thno.54176

Figure Lengend Snippet: The CLDN4 protein and mRNA level of Caco-2 cell monolayers after treatment. (A) Western blot results of CLDN4 after 2 h of PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles incubation at a concentration of 5 µg PCB/mL or removing. (B) Western bands were scanned and normalized to the gray values of internal control β-actin. Quantified results of CLDN4 in (A) using ImageJ. The data was relative to the untreated control in each Western band. The untreated control was settled to 1. (C) Fluorescence images collected by CLSM after 2 h of PCB 122 /INS particles treatment or removal. CLDN4 was shown in green, and cell nuclei stained with DAPI were in blue. (D) Relative CLDN4 mRNA level in Caco-2 cells after 2 h of PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles incubation or removal. The mean ± SD was shown (n = 3). * P < 0.05, ** P < 0.01.

Article Snippet: Anti-integrin αV and β1 antibodies were purchased from Affinity Biosciences LTD. All plates used in cellular experiments were Corning Incorporated.

Techniques: Western Blot, Incubation, Concentration Assay, Control, Fluorescence, Staining

The mechanism for PCB/INS particles opening the tight junctions. (A) Western blot results of CLDN4 expression after 2 h of PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles treatment in the presence of bafilomycin A1. Western bands were scanned and normalized to the gray values of internal control β-actin. The results were quantified using ImageJ. (B) Western blot results of CLDN4 expression after 2 h of PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles treatment in the presence of various endocytic inhibitors. (C) Fluorescence images of Caco-2 cell monolayers after incubation with PCB 122 /INS particles for 2 h. CLDN4 was shown in green. Endosomes/lysosomes stained with LysoTracker deep red were in red. Cell nuclei stained with DAPI were in blue. (D) Fluorescence images collected by CLSM. F-actin stained with FITC-labeled phalloidin was shown in green, and the cell nuclei stained with DAPI were in blue. (E) Western blot results of CLDN4 expression after 2 h of PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles treatment in the presence of integrin αV antibody or integrin β1 antibody. (F) Western bands were scanned and normalized to the gray values of internal control β-actin. Quantified results of CLDN4 in (E) using ImageJ. (G) The schematic diagram for the mechanism. For Western blot, the data was relative to the untreated control in each Western band. The untreated control was settled to 1. The mean ± SD was shown (n = 3).

Journal: Theranostics

Article Title: Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery

doi: 10.7150/thno.54176

Figure Lengend Snippet: The mechanism for PCB/INS particles opening the tight junctions. (A) Western blot results of CLDN4 expression after 2 h of PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles treatment in the presence of bafilomycin A1. Western bands were scanned and normalized to the gray values of internal control β-actin. The results were quantified using ImageJ. (B) Western blot results of CLDN4 expression after 2 h of PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles treatment in the presence of various endocytic inhibitors. (C) Fluorescence images of Caco-2 cell monolayers after incubation with PCB 122 /INS particles for 2 h. CLDN4 was shown in green. Endosomes/lysosomes stained with LysoTracker deep red were in red. Cell nuclei stained with DAPI were in blue. (D) Fluorescence images collected by CLSM. F-actin stained with FITC-labeled phalloidin was shown in green, and the cell nuclei stained with DAPI were in blue. (E) Western blot results of CLDN4 expression after 2 h of PCB 23 /INS, PCB 36 /INS and PCB 122 /INS particles treatment in the presence of integrin αV antibody or integrin β1 antibody. (F) Western bands were scanned and normalized to the gray values of internal control β-actin. Quantified results of CLDN4 in (E) using ImageJ. (G) The schematic diagram for the mechanism. For Western blot, the data was relative to the untreated control in each Western band. The untreated control was settled to 1. The mean ± SD was shown (n = 3).

Article Snippet: Anti-integrin αV and β1 antibodies were purchased from Affinity Biosciences LTD. All plates used in cellular experiments were Corning Incorporated.

Techniques: Western Blot, Expressing, Control, Fluorescence, Incubation, Staining, Labeling

PCB 122 /INS particles enabled oral insulin delivery in STZ-induced type 1 diabetic rats. (A) Variation of blood glucose levels of diabetic rats after treatment for 12 h. (B) Variation of serum insulin level of diabetic rats after treatment for 12 h. Diabetic rats were orally administered PCB/INS particles, insulin solution at a dose of 75 IU/kg, PCB/INS particles in capsules at a dose of 50 IU/kg. Subcutaneous (SC) injection of insulin solution at a dose of 5 IU/kg, or saline via gavage. (C) Variation of blood glucose levels of diabetic rats after treatment. (D) Variation of serum insulin level of diabetic rats after treatment. Diabetic rats were orally administered PCB 122 /INS particles at a dose of 75 IU/kg and PCB 122 /INS particles in capsules at a dose of 50 IU/kg once a day for five consecutive days. (E) In vivo glucose tolerance test toward diabetic mice 4 h post-administration of PCB 122 /INS particles at a dose of 75 IU/kg or PCB 122 /INS particles in capsules at a dose of 50 IU/kg. The mean ± SD was shown (n = 5).

Journal: Theranostics

Article Title: Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery

doi: 10.7150/thno.54176

Figure Lengend Snippet: PCB 122 /INS particles enabled oral insulin delivery in STZ-induced type 1 diabetic rats. (A) Variation of blood glucose levels of diabetic rats after treatment for 12 h. (B) Variation of serum insulin level of diabetic rats after treatment for 12 h. Diabetic rats were orally administered PCB/INS particles, insulin solution at a dose of 75 IU/kg, PCB/INS particles in capsules at a dose of 50 IU/kg. Subcutaneous (SC) injection of insulin solution at a dose of 5 IU/kg, or saline via gavage. (C) Variation of blood glucose levels of diabetic rats after treatment. (D) Variation of serum insulin level of diabetic rats after treatment. Diabetic rats were orally administered PCB 122 /INS particles at a dose of 75 IU/kg and PCB 122 /INS particles in capsules at a dose of 50 IU/kg once a day for five consecutive days. (E) In vivo glucose tolerance test toward diabetic mice 4 h post-administration of PCB 122 /INS particles at a dose of 75 IU/kg or PCB 122 /INS particles in capsules at a dose of 50 IU/kg. The mean ± SD was shown (n = 5).

Article Snippet: Anti-integrin αV and β1 antibodies were purchased from Affinity Biosciences LTD. All plates used in cellular experiments were Corning Incorporated.

Techniques: Capsules, Injection, Saline, In Vivo

The biocompatibility and safety of PCB 122 /INS particles. (A) Western blot results of CLDN4 in small intestine of diabetic rats treated with PCB 122 /INS particles for 24 h. Western bands were scanned and normalized to the gray values of internal control GAPDH. The results were quantified using ImageJ. The data was relative to the untreated control in each Western band. The untreated control was settled to 1. The mean ± SD was shown (n = 3). (B) Fluorescence images of small intestines collected by CLSM. CLDN4 was shown in red, and cell nuclei stained with DAPI were in blue. The scale bar was 50 µm. (C-F) The endotoxin and pro-inflammatory cytokines in blood serum that was collected 24 h after the last administration. (G) Hematoxylin-eosin staining of small intestines. The scale bar was 100 µm. Diabetic rats were orally administered PCB 122 /INS particles at a dose of 75 IU/kg and PCB 122 /INS particles in capsules at a dose of 50 IU/kg once a day for five consecutive days. The mean ± SD was shown (n = 5). * P < 0.05, ** P < 0.01, *** P < 0.001.

Journal: Theranostics

Article Title: Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery

doi: 10.7150/thno.54176

Figure Lengend Snippet: The biocompatibility and safety of PCB 122 /INS particles. (A) Western blot results of CLDN4 in small intestine of diabetic rats treated with PCB 122 /INS particles for 24 h. Western bands were scanned and normalized to the gray values of internal control GAPDH. The results were quantified using ImageJ. The data was relative to the untreated control in each Western band. The untreated control was settled to 1. The mean ± SD was shown (n = 3). (B) Fluorescence images of small intestines collected by CLSM. CLDN4 was shown in red, and cell nuclei stained with DAPI were in blue. The scale bar was 50 µm. (C-F) The endotoxin and pro-inflammatory cytokines in blood serum that was collected 24 h after the last administration. (G) Hematoxylin-eosin staining of small intestines. The scale bar was 100 µm. Diabetic rats were orally administered PCB 122 /INS particles at a dose of 75 IU/kg and PCB 122 /INS particles in capsules at a dose of 50 IU/kg once a day for five consecutive days. The mean ± SD was shown (n = 5). * P < 0.05, ** P < 0.01, *** P < 0.001.

Article Snippet: Anti-integrin αV and β1 antibodies were purchased from Affinity Biosciences LTD. All plates used in cellular experiments were Corning Incorporated.

Techniques: Western Blot, Control, Fluorescence, Staining, Capsules